BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23807368)

  • 21. Association between HLA-G 14-bp insertion/deletion polymorphism and hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection.
    Kim SK; Chung JH; Jeon JW; Park JJ; Cha JM; Joo KR; Lee JI; Shin HP
    Hepatogastroenterology; 2013 Jun; 60(124):796-8. PubMed ID: 23732778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between IL6 -572G/C polymorphism and hepatocellular carcinoma in men].
    Liu S; Qiu XQ; Zeng XY; Bai H; Bei CH; Yang Y
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):463-7. PubMed ID: 23044206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
    Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
    Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai.
    Kimkong I; Chankaew J; Kunanopparat A; Hirankarn N; Tangkijvanich P
    Tissue Antigens; 2015 Mar; 85(3):177-81. PubMed ID: 25664396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B.
    Hoan NX; Van Tong H; Giang DP; Cuong BK; Toan NL; Wedemeyer H; Bock CT; Kremsner PG; Song LH; Velavan TP
    Oncotarget; 2017 Mar; 8(10):17127-17139. PubMed ID: 28179578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Estrogen receptor gene polymorphisms and HBV-induced liver cirrhosis].
    Xie JP; Gong XQ; Tan DM; Liu F; Zhou JL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):379-82. PubMed ID: 16859128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
    Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
    J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection.
    Sy BT; Hoan NX; Tong HV; Meyer CG; Toan NL; Song LH; Bock CT; Velavan TP
    World J Gastroenterol; 2018 Jan; 24(2):248-256. PubMed ID: 29375210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relations between IL-2-330 polymorphisms and the outcome of hepatitis B and/or hepatitis C virus infection].
    Gao QJ; Liu DW; Zhang SY; Wu LH; Jia M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Sep; 31(9):1041-5. PubMed ID: 21162873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of LTBR polymorphisms with chronic hepatitis B virus infection and hepatitis B virus-related hepatocellular carcinoma.
    Zhu Q; Li N; Li F; Sang J; Deng H; Han Q; Lv Y; Li C; Liu Z
    Int Immunopharmacol; 2017 Aug; 49():126-131. PubMed ID: 28575727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
    Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
    Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
    Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms of interferon gamma gene and risk of hepatocellular carcinoma in korean patients with chronic hepatitis B viral infection.
    Kim HJ; Chung JH; Shin HP; Jeon JW; Park JJ; Cha JM; Joo KR; Lee JI
    Hepatogastroenterology; 2013; 60(125):1117-20. PubMed ID: 23803376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus.
    Gulnaz A; Sayyed AH; Amin F; Khan Au; Aslam MA; Shaikh RS; Ali M
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):166-79. PubMed ID: 23044807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.
    Weng CJ; Hsieh YH; Tsai CM; Chu YH; Ueng KC; Liu YF; Yeh YH; Su SC; Chen YC; Chen MK; Yang SF
    Ann Surg Oncol; 2010 Jul; 17(7):1808-15. PubMed ID: 20119675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
    J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship of interleukin-18 gene promoter polymorphisms with chronic hepatitis B in Chinese Han population].
    Zhang PA; Wu JM; Li Y; Yang XS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):528-32. PubMed ID: 16215941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
    Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS
    Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.